|
US3843662A
(en)
|
1971-12-09 |
1974-10-22 |
Pfizer |
2-halo-5-(substituted piperidino sulfonyl)benzoic acids
|
|
AU1508183A
(en)
|
1982-06-04 |
1983-12-08 |
Beecham Group Plc |
Benzamide and anilide derivatives of 8-azabicyclo-(3.2.1)- -octane
|
|
WO1984003281A1
(en)
|
1983-02-19 |
1984-08-30 |
Beecham Group Plc |
Azabicycloalkyl benzamide and anilide derivatives
|
|
JPS62142164A
(ja)
|
1985-12-13 |
1987-06-25 |
Ishihara Sangyo Kaisha Ltd |
４，５−ジクロロイミダゾ−ル系化合物及びそれらを含有する有害生物防除剤
|
|
IN164880B
(enExample)
|
1986-01-30 |
1989-06-24 |
Ishihara Sangyo Kaisha |
|
|
US5272167A
(en)
|
1986-12-10 |
1993-12-21 |
Schering Corporation |
Pharmaceutically active compounds
|
|
GB8904174D0
(en)
|
1989-02-23 |
1989-04-05 |
British Bio Technology |
Compounds
|
|
US4962101A
(en)
|
1989-08-21 |
1990-10-09 |
Merck & Co., Inc. |
2-(Heterocyclylalkyl)phenyl carbapenem antibacterial agents
|
|
GB9023082D0
(en)
|
1990-10-24 |
1990-12-05 |
Schering Agrochemicals Ltd |
Fungicides
|
|
GB9109557D0
(en)
|
1991-05-02 |
1991-06-26 |
Wellcome Found |
Chemical compounds
|
|
US5308826A
(en)
|
1993-04-22 |
1994-05-03 |
Zeneca Limited |
Herbicidal 4-substituted pyridyl-3-carbinols
|
|
US5795907A
(en)
|
1994-05-27 |
1998-08-18 |
James Black Foundation Limited |
Gastin and CCK receptor ligands
|
|
US5912260A
(en)
|
1994-05-27 |
1999-06-15 |
James Black Foundation Limited |
Gastrin and CCK antagonists
|
|
US5763618A
(en)
|
1995-05-12 |
1998-06-09 |
Konica Corporation |
Manufacturing method of sulfides
|
|
US5723411A
(en)
|
1995-10-31 |
1998-03-03 |
E. I. Du Pont De Nemours And Company |
Herbicidal pyridazinones
|
|
DE19540995A1
(de)
|
1995-11-03 |
1997-05-07 |
Hoechst Ag |
Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
|
GB9612884D0
(en)
|
1996-06-20 |
1996-08-21 |
Smithkline Beecham Plc |
Novel compounds
|
|
EP0912550A1
(en)
|
1996-06-25 |
1999-05-06 |
Smithkline Beecham Plc |
Sulfonamide derivatives as 5ht7 receptor antagonists
|
|
AU5127098A
(en)
|
1996-11-29 |
1998-06-22 |
Smithkline Beecham Plc |
Use of a combination of penciclovir and alpha-interferon in the manufacture of a medicament for the treatment of hepatitis
|
|
US5939423A
(en)
|
1997-04-16 |
1999-08-17 |
Sciclone Pharmaceuticals, Inc. |
Treatment of hepatitis B infection with thymosin alpha 1 and famciclovir
|
|
US5919970A
(en)
|
1997-04-24 |
1999-07-06 |
Allergan Sales, Inc. |
Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
|
|
US5994396A
(en)
|
1997-08-18 |
1999-11-30 |
Centaur Pharmaceuticals, Inc. |
Furansulfonic acid derivatives and pharmaceutical compositions containing the same
|
|
US6200995B1
(en)
|
1998-01-29 |
2001-03-13 |
Tularik Inc. |
PPAR-γ modulators
|
|
EP1072263A4
(en)
|
1998-03-26 |
2004-03-31 |
Japan Tobacco Inc |
AMID DERIVATIVES AND NOCICEPTINANT AGONISTS
|
|
US6251893B1
(en)
|
1998-06-15 |
2001-06-26 |
Nps Allelix Corp. |
Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity
|
|
EP1147089B1
(en)
|
1999-01-15 |
2005-12-07 |
ALTANA Pharma AG |
Phenylphenanthridines with pde-iv inhibiting activity
|
|
AU6068600A
(en)
|
1999-07-16 |
2001-02-05 |
Warner-Lambert Company |
Method for treating chronic pain using mek inhibitors
|
|
JP2003506406A
(ja)
|
1999-08-10 |
2003-02-18 |
ザ・チャンセラー・マスターズ・アンド・スカラーズ・オブ・ザ・ユニバーシティ・オブ・オックスフォード |
長鎖ｎ−アルキル化合物およびそのオキサ誘導体
|
|
EP1216228B1
(en)
|
1999-09-17 |
2008-10-29 |
Millennium Pharmaceuticals, Inc. |
BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
|
|
WO2001051487A1
(en)
|
1999-12-28 |
2001-07-19 |
Pfizer Products Inc. |
Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
|
|
WO2001055121A1
(en)
|
2000-01-28 |
2001-08-02 |
Kaken Pharmaceutical Co., Ltd. |
Azepine derivatives
|
|
US6511980B2
(en)
|
2000-05-05 |
2003-01-28 |
Ortho Mcneil Pharmaceutical, Inc. |
Substituted diamine derivatives useful as motilin antagonists
|
|
EP1193268A1
(en)
|
2000-09-27 |
2002-04-03 |
Applied Research Systems ARS Holding N.V. |
Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases
|
|
WO2002051410A2
(en)
|
2000-12-22 |
2002-07-04 |
Akzo Nobel N.V. |
Phenylthiazole and thiazoline derivatives and their use as antiparasitics
|
|
CA2432076A1
(en)
|
2000-12-27 |
2002-07-11 |
Sumitomo Pharmaceuticals Co., Ltd. |
Novel antibacterial carbapenem compounds
|
|
AU2002248418A1
(en)
|
2001-02-09 |
2002-08-28 |
Massachusetts Institute Of Technology |
Methods of identifying agents that mediate polypeptide aggregation
|
|
US6650463B2
(en)
|
2001-03-13 |
2003-11-18 |
Seiko Epson Corporation |
Electrophoretic display device
|
|
WO2003007955A2
(en)
|
2001-07-20 |
2003-01-30 |
Cancer Research Technology Limited |
Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer
|
|
DE10136043A1
(de)
|
2001-07-25 |
2003-02-13 |
Degussa |
Verfahren zur Herstellung von modifiziertem Ruß
|
|
US6956035B2
(en)
|
2001-08-31 |
2005-10-18 |
Inotek Pharmaceuticals Corporation |
Isoquinoline derivatives and methods of use thereof
|
|
DE60204718T2
(de)
|
2001-11-20 |
2006-05-18 |
Eli Lilly And Co., Indianapolis |
3-substituierte oxindol beta 3 agonisten
|
|
SE0201635D0
(sv)
|
2002-05-30 |
2002-05-30 |
Astrazeneca Ab |
Novel compounds
|
|
US20060100257A1
(en)
|
2002-06-05 |
2006-05-11 |
Susumu Muto |
Inhibitors against the activation of ap-1 and nfat
|
|
KR101124245B1
(ko)
|
2002-06-27 |
2012-07-02 |
노보 노르디스크 에이/에스 |
치료제로서 아릴 카르보닐 유도체
|
|
KR101116627B1
(ko)
|
2002-06-27 |
2012-10-09 |
노보 노르디스크 에이/에스 |
치료제로서 아릴 카르보닐 유도체
|
|
AU2003254177A1
(en)
|
2002-07-31 |
2004-02-16 |
Smithkline Beecham Corporation |
Substituted benzanilides as modulators of the ccr5 receptor
|
|
AU2003256923A1
(en)
|
2002-07-31 |
2004-02-16 |
Smithkline Beecham Corporation |
Substituted benzanilides as modulators of the ccr5 receptor
|
|
US7186735B2
(en)
|
2002-08-07 |
2007-03-06 |
Sanofi-Aventis Deutschland Gmbh |
Acylated arylcycloalkylamines and their use as pharmaceuticals
|
|
US7338956B2
(en)
|
2002-08-07 |
2008-03-04 |
Sanofi-Aventis Deutschland Gmbh |
Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
|
|
JP4399862B2
(ja)
|
2002-08-09 |
2010-01-20 |
味の素株式会社 |
腸疾患および内臓痛の治療薬
|
|
EP1545532A2
(en)
|
2002-09-06 |
2005-06-29 |
Janssen Pharmaceutica N.V. |
Heterocyclic compounds
|
|
SE0202838D0
(sv)
|
2002-09-24 |
2002-09-24 |
Astrazeneca Ab |
Chemical compounds
|
|
WO2004058709A1
(en)
|
2002-12-23 |
2004-07-15 |
Millennium Pharmaceuticals, Inc. |
Ccr8 inhibitors
|
|
US7320989B2
(en)
|
2003-02-28 |
2008-01-22 |
Encysive Pharmaceuticals, Inc. |
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
|
|
ATE524452T1
(de)
|
2003-03-27 |
2011-09-15 |
Cytokinetics Inc |
Sulfonamide zur behandlung von kongestivem herzversagen, deren zusammensetzungen und verwendungen.
|
|
EP1628970A2
(en)
|
2003-04-30 |
2006-03-01 |
The Institutes of Pharmaceutical Discovery, LLC |
Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
|
|
JP2006528685A
(ja)
|
2003-05-06 |
2006-12-21 |
スミスクライン ビーチャム コーポレーション |
新規化合物
|
|
ES2308206T3
(es)
|
2003-05-13 |
2008-12-01 |
Schering Corporation |
N-arilsulfonilpiperidinas con fuentes como inhibidores de gamma-secretasa.
|
|
WO2005007621A2
(en)
|
2003-05-30 |
2005-01-27 |
Rigel Pharmaceuticals, Inc. |
Ubiquitin ligase inhibitors
|
|
US20110275630A1
(en)
|
2003-06-02 |
2011-11-10 |
Abbott Laboratories |
Isoindolinone kinase inhibitors
|
|
AR045047A1
(es)
|
2003-07-11 |
2005-10-12 |
Arena Pharm Inc |
Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
|
|
GB0319151D0
(en)
|
2003-08-14 |
2003-09-17 |
Glaxo Group Ltd |
Novel compounds
|
|
EP1678147B1
(en)
|
2003-09-15 |
2012-08-08 |
Lead Discovery Center GmbH |
Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
|
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
|
US7498050B2
(en)
|
2003-12-15 |
2009-03-03 |
Kraft Foods Global Brands Llc |
Edible spread composition and packaged product
|
|
DE102004009238A1
(de)
|
2004-02-26 |
2005-09-08 |
Merck Patent Gmbh |
Arylamid-Derivate
|
|
US8404747B2
(en)
|
2004-03-05 |
2013-03-26 |
The General Hospital Corporation |
Compositions and methods for modulating interaction between polypeptides
|
|
WO2005105785A2
(en)
|
2004-05-04 |
2005-11-10 |
Novo Nordisk A/S |
Indole derivatives for treatment of obesity
|
|
US20090105218A1
(en)
|
2004-05-29 |
2009-04-23 |
7Tm Pharma A/S |
CRTH2 Receptor Ligands For Therapeutic Use
|
|
JP2008503585A
(ja)
|
2004-06-22 |
2008-02-07 |
シェーリング コーポレイション |
カンナビノイドレセプターリガンド
|
|
MX2007002434A
(es)
|
2004-08-31 |
2007-05-04 |
Astrazeneca Ab |
Derivados de quinazolinona y su uso como inhibidores de b-raf.
|
|
DE102004042441A1
(de)
|
2004-08-31 |
2006-04-06 |
Sanofi-Aventis Deutschland Gmbh |
Mit Aminosäuren substituierte Hexahydro-pyrazino(1,2-a)pyrimidin-4,7-dionderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
EP1807399A2
(en)
|
2004-10-19 |
2007-07-18 |
Novartis Vaccines and Diagnostics, Inc. |
Indole and benzimidazole derivatives
|
|
TW200628463A
(en)
|
2004-11-10 |
2006-08-16 |
Synta Pharmaceuticals Corp |
Heteroaryl compounds
|
|
US20060122236A1
(en)
|
2004-12-06 |
2006-06-08 |
Wood Michael R |
Substituted biaryl-carboxylate derivatives
|
|
WO2006067445A2
(en)
|
2004-12-22 |
2006-06-29 |
Astrazeneca Ab |
Csf-1r kinase inhibitors
|
|
EP1831198B1
(en)
|
2004-12-22 |
2009-04-08 |
AstraZeneca AB |
Pyridine carboxamide derivatives for use as anticancer agents
|
|
FI117653B
(fi)
|
2005-02-21 |
2006-12-29 |
Eigenor Oy |
Menetelmä ja laitteisto liikkuvien kohteiden havaitsemiseksi tutkalla
|
|
GB0510141D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B3
|
|
US20070032493A1
(en)
|
2005-05-26 |
2007-02-08 |
Synta Pharmaceuticals Corp. |
Method for treating B cell regulated autoimmune disorders
|
|
WO2006128129A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating cancer
|
|
US7790726B2
(en)
|
2005-08-16 |
2010-09-07 |
Chemocentryx, Inc. |
Monocyclic and bicyclic compounds and methods of use
|
|
DK1940786T3
(da)
|
2005-09-16 |
2010-11-08 |
Arrow Therapeutics Ltd |
Biphenylderivater og deres anvendelse ved behandling af hepatitis C
|
|
JP2009521452A
(ja)
|
2005-12-21 |
2009-06-04 |
シェーリング コーポレイション |
コレステロール降下剤およびｈ３受容体アンタゴニスト／逆アゴニストを使用する非アルコール性脂肪性肝疾患の処置
|
|
US20090018118A1
(en)
|
2005-12-29 |
2009-01-15 |
Uros Urleb |
Heterocyclic compounds
|
|
CN101437824B
(zh)
|
2006-05-04 |
2013-03-13 |
肝炎与病毒研究所 |
用于慢性肝炎病毒治疗的乙型肝炎病毒抗原分泌的抑制剂
|
|
US20080021063A1
(en)
|
2006-07-18 |
2008-01-24 |
Kazantsev Aleksey G |
Compositions and methods for modulating sirtuin activity
|
|
US8153803B2
(en)
|
2006-07-18 |
2012-04-10 |
The General Hospital Corporation |
Compositions and methods for modulating sirtuin activity
|
|
FR2903985B1
(fr)
|
2006-07-24 |
2008-09-05 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
|
|
FR2904316B1
(fr)
|
2006-07-31 |
2008-09-05 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique.
|
|
US20100016310A1
(en)
|
2006-08-17 |
2010-01-21 |
Boehringer Ingelheim International Gmbh |
Methods of using aryl sulfonyl compounds effective as soluble epoxide hydrolase inhibitors
|
|
WO2008076270A2
(en)
|
2006-12-13 |
2008-06-26 |
Temple University-Of The Commonwealth System Of Higher Education |
Sulfide, sulfoxide and sulfone chalcone analogues, derivatives thereof and therapeutic uses thereof
|
|
US20100022517A1
(en)
|
2006-12-18 |
2010-01-28 |
Richards Lori A |
Ophthalmic formulation of rho kinase inhibitor compound
|
|
US8071779B2
(en)
|
2006-12-18 |
2011-12-06 |
Inspire Pharmaceuticals, Inc. |
Cytoskeletal active rho kinase inhibitor compounds, composition and use
|
|
FR2910473B1
(fr)
|
2006-12-26 |
2009-02-13 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-pyrrolopyridine-2- carboxamides, leur preparation et leur application en therapeutique.
|
|
JP2008179621A
(ja)
|
2006-12-28 |
2008-08-07 |
Taisho Pharmaceutical Co Ltd |
含窒素飽和複素環化合物
|
|
JP2008184403A
(ja)
|
2007-01-29 |
2008-08-14 |
Japan Health Science Foundation |
新規ｃ型肝炎ウイルス阻害剤
|
|
DK2137162T3
(en)
|
2007-03-15 |
2018-11-26 |
Novartis Ag |
Organic compounds and their applications
|
|
US8097728B2
(en)
|
2007-04-30 |
2012-01-17 |
Philadelphia Health & Education Corporation |
Iminosugar compounds with antiflavirus activity
|
|
JP5160637B2
(ja)
|
2007-05-04 |
2013-03-13 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
ｃ−ｋｉｔおよびＰＤＧＦＲキナーゼインヒビターとしての化合物および組成物
|
|
WO2008154819A1
(fr)
|
2007-06-18 |
2008-12-24 |
Zhang, Zhongneng |
Thiazolyl-dihydropyrimidines à substitution carbéthoxy
|
|
KR20100039429A
(ko)
|
2007-08-02 |
2010-04-15 |
에프. 호프만-라 로슈 아게 |
Ｃｎｓ 질환의 치료를 위한 벤즈아미드 유도체의 용도
|
|
CN101429166B
(zh)
|
2007-11-07 |
2013-08-21 |
上海特化医药科技有限公司 |
喹唑啉酮衍生物及其制备方法和用途
|
|
AU2008345225A1
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
FR2926556B1
(fr)
|
2008-01-22 |
2010-02-19 |
Sanofi Aventis |
Derives de carboxamides n-azabicycliques, leur preparation et leur application en therapeutique
|
|
FR2926555B1
(fr)
|
2008-01-22 |
2010-02-19 |
Sanofi Aventis |
Derives bicycliques de carboxamides azabicycliques, leur preparation et leur application en therapeutique
|
|
FR2926554B1
(fr)
|
2008-01-22 |
2010-03-12 |
Sanofi Aventis |
Derives de carboxamides azabicycliques, leur preparation et leur application en therapeutique
|
|
FR2926553B1
(fr)
|
2008-01-23 |
2010-02-19 |
Sanofi Aventis |
Derives d'indole-2-carboxamides et d'azaindole-2- carboxamides substitues par un groupe silanyle, leur preparation et leur application en therapeutique
|
|
WO2009146013A1
(en)
|
2008-03-31 |
2009-12-03 |
Georgetown University |
Myosin light chain phosphatase inhibitors
|
|
JP5501226B2
(ja)
|
2008-04-24 |
2014-05-21 |
Ｍｓｄ株式会社 |
アリールスルホニル誘導体を有効成分とする長鎖脂肪酸伸長酵素阻害剤
|
|
US8299096B2
(en)
|
2008-06-26 |
2012-10-30 |
Inspire Pharmaceuticals, Inc. |
Method for treating pulmonary diseases using rho kinase inhibitor compounds
|
|
US20100008968A1
(en)
|
2008-06-26 |
2010-01-14 |
Lampe John W |
Method for treating cardiovascular diseases using rho kinase inhibitor compounds
|
|
US8207195B2
(en)
|
2008-06-26 |
2012-06-26 |
Inspire Pharmaceuticals, Inc. |
Method for treating neurological and neuropathic diseases using rho kinase inhibitor compounds
|
|
US20090325959A1
(en)
|
2008-06-26 |
2009-12-31 |
Vittitow Jason L |
Method for treating ophthalmic diseases using rho kinase inhibitor compounds
|
|
US20090325960A1
(en)
|
2008-06-26 |
2009-12-31 |
Fulcher Emilee H |
Method for treating inflammatory diseases using rho kinase inhibitor compounds
|
|
US8410147B2
(en)
|
2008-06-26 |
2013-04-02 |
Inspire Pharmaceuticals, Inc. |
Method for treating diseases associated with alterations in cellular integrity using Rho kinase inhibitor compounds
|
|
CN102149677A
(zh)
|
2008-08-15 |
2011-08-10 |
霍夫曼-拉罗奇有限公司 |
联芳基氨基四氢化萘类
|
|
WO2010027996A1
(en)
|
2008-09-02 |
2010-03-11 |
Institute For Hepatitis And Virus Research |
Novel imino sugar derivatives demonstrate potent antiviral activity and reduced toxicity
|
|
WO2010043592A1
(en)
|
2008-10-15 |
2010-04-22 |
Revotar Biopharmaceuticals Ag |
Lipase inhibitors for use for the treatment of obesity
|
|
EP2400969A4
(en)
|
2008-12-04 |
2012-05-16 |
Inspire Pharmaceuticals Inc |
METHOD FOR TREATING PULMONARY DISEASES USING RHO KINASE INHIBITORY COMPOUNDS
|
|
EP2379556A1
(en)
|
2008-12-30 |
2011-10-26 |
ArQule, Inc. |
Substituted 1h-pyrazolo[3,4-d]pyrimidine-6-amine compounds
|
|
WO2010088000A2
(en)
|
2009-02-02 |
2010-08-05 |
Angion Biomedica Corp. |
Antifibrotic compounds and uses thereof
|
|
WO2010123139A1
(ja)
|
2009-04-24 |
2010-10-28 |
持田製薬株式会社 |
スルファモイル基を有するアリールカルボキサミド誘導体
|
|
WO2011002635A1
(en)
|
2009-06-30 |
2011-01-06 |
Siga Technologies, Inc. |
Treatment and prevention of dengue virus infections
|
|
US8703938B2
(en)
|
2009-09-11 |
2014-04-22 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8822700B2
(en)
|
2009-09-11 |
2014-09-02 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US20120252792A1
(en)
|
2009-09-17 |
2012-10-04 |
The Regents Of The University Of Michigan |
Methods and compositions for modulating rho-mediated gene transcription
|
|
US9051296B2
(en)
|
2009-11-16 |
2015-06-09 |
Raqualia Pharma Inc. |
Aryl carboxamide derivatives as TTX-S blockers
|
|
CN102093320B
(zh)
|
2009-12-09 |
2013-08-28 |
扬子江药业集团上海海尼药业有限公司 |
一种可溶性环氧化物水解酶抑制剂
|
|
EP2523936A1
(en)
|
2010-01-15 |
2012-11-21 |
Boehringer Ingelheim International GmbH |
Compounds which modulate the cb2 receptor
|
|
WO2011088561A1
(en)
|
2010-01-20 |
2011-07-28 |
University Of Manitoba |
Anti-viral compounds and compositions
|
|
WO2011109237A2
(en)
|
2010-03-02 |
2011-09-09 |
Emory University |
Uses of noscapine and derivatives in subjects diagnosed with fap
|
|
JP2013522192A
(ja)
|
2010-03-11 |
2013-06-13 |
ブリストル−マイヤーズ スクイブ カンパニー |
Ｃ型肝炎の処置のための化合物
|
|
US20130018039A1
(en)
|
2010-03-31 |
2013-01-17 |
Bodmer Vera Q |
Imidazolyl-imidazoles as kinase inhibitors
|
|
HRP20170736T1
(hr)
|
2010-05-07 |
2017-07-28 |
Glaxosmithkline Llc |
Indoli
|
|
US8993622B2
(en)
|
2010-06-11 |
2015-03-31 |
Eirium Ab |
Antiviral compounds
|
|
US20130142827A1
(en)
|
2010-06-25 |
2013-06-06 |
Philadelphia Health & Education Corporation D/B/A |
Induction of immune response
|
|
MX2013000664A
(es)
|
2010-07-19 |
2013-03-07 |
Inspire Pharmaceuticals Inc |
Compuestos bifuncionales inhibidores de quinasa de rho, composicion y usos.
|
|
WO2012018635A2
(en)
|
2010-07-26 |
2012-02-09 |
Neurotherapeutics Pharma, Inc. |
Arylsulfonamide derivatives, compositions, and methods of use
|
|
CA2803689A1
(en)
|
2010-07-27 |
2012-02-02 |
Inspire Pharmaceuticals, Inc. |
Method for treating ophthalmic diseases using kinase inhibitor compounds in prodrug forms
|
|
WO2012016133A2
(en)
|
2010-07-29 |
2012-02-02 |
President And Fellows Of Harvard College |
Ros1 kinase inhibitors for the treatment of glioblastoma and other p53-deficient cancers
|
|
WO2012033956A1
(en)
|
2010-09-08 |
2012-03-15 |
Mithridion, Inc. |
Cognition enhancing compounds and compositions, methods of making, and methods of treating
|
|
EP2624837A4
(en)
|
2010-10-04 |
2014-03-26 |
Inst Hepatitis & Virus Res |
NEW HEMMER OF THE SECRETION OF HEPATITIS B VIRUS ANTIGENES
|
|
GB201017345D0
(en)
|
2010-10-14 |
2010-11-24 |
Proximagen Ltd |
Receptor antagonists
|
|
ES2585396T3
(es)
|
2010-12-02 |
2016-10-05 |
VIIV Healthcare UK (No.5) Limited |
Alquilamidas como inhibidores de la unión del VIH
|
|
WO2012080050A1
(en)
|
2010-12-14 |
2012-06-21 |
F. Hoffmann-La Roche Ag |
Solid forms of a phenoxybenzenesulfonyl compound
|
|
GB201103419D0
(enExample)
|
2011-02-28 |
2011-04-13 |
Univ Aberdeen |
|
|
EA027792B1
(ru)
|
2011-04-08 |
2017-09-29 |
Янссен Сайенсиз Айрлэнд Юси |
Производные пиримидина для лечения вирусных инфекций
|
|
US8889716B2
(en)
|
2011-05-10 |
2014-11-18 |
Chdi Foundation, Inc. |
Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof
|
|
EP2726459B1
(en)
|
2011-07-01 |
2019-09-11 |
Baruch S. Blumberg Institute |
Sulfamoylbenzamide derivatives as antiviral agents against hbv infection
|
|
JP5977837B2
(ja)
|
2011-12-21 |
2016-08-24 |
ノヴィラ・セラピューティクス・インコーポレイテッド |
Ｂ型肝炎抗ウイルス剤
|
|
CN104302626B
(zh)
|
2012-01-06 |
2016-09-07 |
爱尔兰詹森科学公司 |
4,4-二取代的-1,4-二氢嘧啶及其作为治疗乙型肝炎的药物的用途
|
|
WO2013130703A2
(en)
|
2012-02-29 |
2013-09-06 |
Institute For Hepatitis And Virus Research |
Binhibitors of hepatitis b virus convalently closed circular dna formation and their method of use
|
|
US20130267517A1
(en)
|
2012-03-31 |
2013-10-10 |
Hoffmann-La Roche Inc. |
Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
|
JP6431478B2
(ja)
|
2012-06-01 |
2018-11-28 |
ドレクセル ユニバーシティ |
Ｂ型肝炎ウイルスのｃｃｃｄｎａの転写の調節
|
|
JO3300B1
(ar)
|
2012-06-06 |
2018-09-16 |
Novartis Ag |
مركبات وتركيبات لتعديل نشاط egfr
|
|
TW201408652A
(zh)
|
2012-07-11 |
2014-03-01 |
Hoffmann La Roche |
作爲ＲＯＲｃ調節劑之芳基磺內醯胺衍生物
|
|
EP2890683B1
(en)
|
2012-08-28 |
2016-10-12 |
Janssen Sciences Ireland UC |
Fused bicyclic sulfamoyl derivatives and the use thereof as medicaments for the treatment of hepatitis b
|
|
MX373711B
(es)
|
2012-08-28 |
2020-05-08 |
Janssen Sciences Ireland Uc |
Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b.
|
|
KR20150054795A
(ko)
|
2012-09-10 |
2015-05-20 |
에프. 호프만-라 로슈 아게 |
B형 간염 바이러스 감염의 치료 및 예방을 위한 6-아미노산 헤테로아릴다이하이드로피리미딘
|
|
EP2938338A4
(en)
|
2012-12-27 |
2016-11-23 |
Univ Drexel |
NOVEL ANTIVIRAL AGENTS AGAINST HBV INFECTION
|
|
DK2961732T3
(en)
|
2013-02-28 |
2017-07-10 |
Janssen Sciences Ireland Uc |
SULFAMOYLARYLAMIDS AND USE THEREOF AS MEDICINES TO TREAT HEPATITIS B
|
|
SI2963043T1
(sl)
|
2013-02-28 |
2018-09-28 |
Eisai R&D Management Co., Ltd. |
Derivat tetrahidroimidazo(1,5-d)(1,4)oksazepina
|
|
US8993771B2
(en)
|
2013-03-12 |
2015-03-31 |
Novira Therapeutics, Inc. |
Hepatitis B antiviral agents
|
|
WO2014151958A1
(en)
|
2013-03-14 |
2014-09-25 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
|
CN105102451B
(zh)
|
2013-04-03 |
2018-09-18 |
爱尔兰詹森科学公司 |
N-苯基-氨甲酰衍生物及其作为药物用于治疗乙型肝炎的用途
|
|
DK2997019T3
(en)
|
2013-05-17 |
2018-12-03 |
Janssen Sciences Ireland Uc |
SULFAMOYLTHIOPHENAMIDE DERIVATIVES AND USE THEREOF AS MEDICINES FOR TREATING HEPATITIS B
|
|
JO3603B1
(ar)
|
2013-05-17 |
2020-07-05 |
Janssen Sciences Ireland Uc |
مشتقات سلفامويل بيرولاميد واستخدامها كادوية لمعالجة التهاب الكبد نوع بي
|
|
ES2640794T3
(es)
|
2013-05-28 |
2017-11-06 |
Bayer Cropscience Aktiengesellschaft |
Compuestos heterocíclicos como agentes para el control de plagas
|
|
PE20160874A1
(es)
|
2013-05-28 |
2016-09-04 |
Astrazeneca Ab |
Compuestos quimicos
|
|
WO2014198880A1
(en)
|
2013-06-14 |
2014-12-18 |
Ferrer Internacional, S.A. |
2-(2-aminophenoxy)-3-chloronaphthalene-1,4-dione compounds having orexin 2 receptor agonist activity
|
|
KR102244937B1
(ko)
|
2013-07-25 |
2021-04-27 |
얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 |
글리옥사미드 치환된 피롤아미드 유도체 및 ｂ형 간염 치료용 의약으로서의 이의 용도
|
|
WO2015055764A1
(en)
|
2013-10-18 |
2015-04-23 |
Syngenta Participations Ag |
3-methanimidamid-pyridine derivatives as fungicides
|
|
ES2739435T3
(es)
|
2013-10-18 |
2020-01-31 |
Univ Indiana Res & Tech Corp |
Efectores del ensamblaje viral de la hepatitis B
|
|
DK3060547T3
(en)
|
2013-10-23 |
2018-01-15 |
Janssen Sciences Ireland Uc |
CARBOXAMIDE DERIVATIVES AND USE THEREOF AS MEDICINES FOR TREATMENT OF HEPATITS B
|
|
ES2777248T3
(es)
|
2013-11-14 |
2020-08-04 |
Novira Therapeutics Inc |
Derivados de azepano y métodos de tratar infecciones por hepatitis B
|
|
JO3466B1
(ar)
|
2013-12-20 |
2020-07-05 |
Takeda Pharmaceuticals Co |
مواد ضابطة لتترا هيدرو بيريدوبيرازينات من gpr6
|
|
US9169212B2
(en)
|
2014-01-16 |
2015-10-27 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
|
US9181288B2
(en)
|
2014-01-16 |
2015-11-10 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
|
DK3498692T3
(da)
|
2014-01-31 |
2022-05-16 |
Cognition Therapeutics Inc |
Isoindolin-sammensætninger og fremgangsmåder til behandling af neurodegenerativ sygdom og makulær degeneration
|
|
EP3102225B1
(en)
|
2014-02-05 |
2020-03-25 |
Novira Therapeutics Inc. |
Combination therapy for treatment of hbv infections
|
|
CN110437153A
(zh)
|
2014-03-13 |
2019-11-12 |
美国印第安纳大学研究和技术公司 |
乙型肝炎核心蛋白变构调节剂
|
|
US9400280B2
(en)
|
2014-03-27 |
2016-07-26 |
Novira Therapeutics, Inc. |
Piperidine derivatives and methods of treating hepatitis B infections
|
|
KR20160133563A
(ko)
|
2014-03-28 |
2016-11-22 |
선샤인 레이크 파르마 컴퍼니 리미티드 |
다이하이드로피리미딘 화합물 및 이의 약제학적 용도
|
|
ES2687606T3
(es)
|
2014-05-30 |
2018-10-26 |
Qilu Pharmaceutical Co., Ltd. |
Derivado de bucle de dihidropirimido como inhibidor de HBV
|
|
CA2969557A1
(en)
|
2014-12-02 |
2016-06-09 |
Novira Therapeutics, Inc. |
Sulfide alkyl and pyridyl reverse sulfonamide compounds for hbv treatment
|
|
US9550779B2
(en)
|
2014-12-30 |
2017-01-24 |
Novira Therapeutics, Inc. |
Derivatives and methods of treating hepatitis B infections
|
|
MA41338B1
(fr)
|
2015-01-16 |
2019-07-31 |
Hoffmann La Roche |
Composés de pyrazine pour le traitement de maladies infectieuses
|
|
US9884831B2
(en)
|
2015-03-19 |
2018-02-06 |
Novira Therapeutics, Inc. |
Azocane and azonane derivatives and methods of treating hepatitis B infections
|
|
WO2016161268A1
(en)
|
2015-04-01 |
2016-10-06 |
Enanta Pharmaceuticals, Inc. |
Hepatitis b antviral agents
|
|
CN107922377A
(zh)
|
2015-04-17 |
2018-04-17 |
美国印第安纳大学研究和技术公司 |
乙肝病毒组装效应子
|
|
US10738035B2
(en)
|
2015-05-13 |
2020-08-11 |
Enanta Pharmaceuticals, Inc. |
Hepatitis B antiviral agents
|